wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34664129-404454D7-1682-470D-A6B8-B312A0E878F2
Q34664129-404454D7-1682-470D-A6B8-B312A0E878F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34664129-404454D7-1682-470D-A6B8-B312A0E878F2
Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer.
P2860
Q34664129-404454D7-1682-470D-A6B8-B312A0E878F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34664129-404454D7-1682-470D-A6B8-B312A0E878F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b8f1df9d8737167f9010c2be667a89ffaa57aef9
P2860
Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study.